Skip to main content

Older adults respond well to immunotherapy despite age-related immune system differences

By Johns Hopkins Medicine  
   April 22, 2025

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins Convergence Institute.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.